MissionIR Articles
-
MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Issues Update on Underwritten Public Offering of American Depositary Shares
AnPac Bio (NASDAQ: ANPC) today issued a correction to its press release dated Nov. 9, 2021, regarding the pricing of its underwritten public offering of American Depositary Shares (“ADSs”). According to the update, the original release…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of…
-
MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Strategic Coffee Business Acquisitions
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its acquisition of a majority equity interests in each of Eh Coffee Corp. and Portfolio Coffee Inc. from their respective shareholders for a purchase price comprised…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Jefferies London Healthcare Conference
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to…
-
MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) to Begin Proposed Public Offering
AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced that it is starting an underwritten public offering; the offering is…
-
MissionIRNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Scheduled Release of Q3 2021 Financial Results, Conference Call
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, today announced…
-
MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Expansion of Its Commercial Program in Turkey
Save Foods (NASDAQ: SVFD), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced that Özler…
-
MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) to Participate in Q4 Virtual Investor Summit
AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced its participation in the Q4 Virtual Investor Summit, slated for Nov.…
-
MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) to Pursue Larger Scale Research Collaboration with UC Riverside
Save Foods (NASDAQ: SVFD), an agrifood tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure the safety of fresh fruits and vegetables, today announced increased collaboration…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroFold Platform Brings Key Capabilities Amid Strong Demand for Protein Therapeutics
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, high pressure-based instruments, platform technologies and related consumables for the worldwide life sciences, agriculture, food and beverage, and other key…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Q3 2021 Financial Results Conference Call
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, will be hosting a conference call on Nov. 15, 2021; the call will…
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE) Releases Update on Post-Merger Share Count
Net Element (NASDAQ: NETE), a global technology and value-added solutions group, and Mullen Automotive Inc., an emerging electric vehicle (“EV”) manufacturer, has shared updated information regarding a previously announced definitive stock-for-stock reverse merger agreement between the…
-
MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at Diabetes Technology Society Conference
Nemaura Medical (NASDAQ: NMRD)CEO Faz Chowdhury, PhD, will be presenting at annual meeting of the Diabetes Technology Society. The two-day meeting is slated for Nov. 5–6, 2021, with virtual workshops on Thursday, Nov. 4; Chowdury’s…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters Definitive Agreement to Acquire Vessel Brand Inc.
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has entered into a definitive agreement in respect of the previously announced acquisition of 100% of Vessel Brand Inc. Upon…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Schedules R&D Briefing to Release Breakthrough Research Findings
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, will be hosting an in-person and virtual research and development briefing. Scheduled for Nov. 8, 2021, from 8:30–9:30 a.m. EST, the briefing…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has begun a new study, EPIL-A21-1,designed to evaluate whether its DehydraTECH(TM)-CBD (“CBD”) indicates superior ability to reduce seizure activity compared to both generic cannabidiol and…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Expands Sequire Platform to Launch New Feature
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the release of the Investor Relations Website Feature. The new feature on…
-
MissionIRNewsBreaks – AmpliTech Group Inc. (NASDAQ: AMPG) Receives New Orders Totaling $1.2M
AmpliTech Group (NASDAQ: AMPG), a designer, developer and manufacturer of state-of-the-art signal-processing components for satellite and 5G communications networks, defense, space and other commercial applications, announced that it has received $1.2 million in new orders…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), Consolidated Uranium Inc. (TSX.V: CUR) (OTCQB: CURUF) Complete Acquisition and Strategic Alliance
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, and Consolidated Uranium (TSX.V: CUR) (OTCQB: CURUF) have closed a previously announced acquisition. In July 2021, the two companies announced plans for Consolidated Uranium to…
-
MissionIRNewsBreaks – Net Element Inc.’s (NASDAQ: NETE) Post-Merger Company Announces New Hires to Drive Vehicle Manufacturing Efforts
Mullen Automotive Inc., an emerging electric vehicle (“EV”) manufacturer, which previously announced a definitive stock-for-stock reverse merger agreement with Net Element (NASDAQ: NETE) in which Mullen’s stockholders will receive a majority of the outstanding stock in the…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial